References
- Clary GL, Krishnan KR. Delirium: diagnosis, neuropathogenesis, and treatment. J Psychiatr Pract. 2001;7:310–323.
- Smith SW. Drugs and pharmaceuticals: management of intoxication and antidotes. EXS. 2010;100:397–460.
- Heiser JF, Gillin JC. The reversal of anticholinergic drug-induced delirium and coma with physostigmine. Am J Psychiatry. 1971;127:1050–1054.
- Schneir AB, Offerman SR, Ly BT, et al. Complications of diagnostic physostigmine administration to emergency department patients. Ann Emerg Med. 2003;42:14–19.
- Burns MJ, Linden CH, Graudins A, et al. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med. 2000;35:374–381.
- Knudsen K, Heath A. Effects of self poisoning with maprotiline. Br Med J (Clin Res Ed). 1984;288:601–603.
- Pentel P, Peterson CD. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med. 1980;9:588–590.
- Kulig K, Rumack BH. Physostigmine and asystole. Ann Emerg Med. 1981;10:228–229.
- Shannon M. Toxicology reviews: physostigmine. Pediatr Emerg Care. 1998;14:224–226.
- Suchard JR. Assessing physostigmine's contraindication in cyclic antidepressant ingestions. J Emerg Med. 2003;25:185–191.
- Liebelt EL, Francis PD, Woolf AD. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med. 1995;26:195–201.
- Liebelt EL, Ulrich A, Francis PD, et al. Serial electrocardiogram changes in acute tricyclic antidepressant overdoses. Crit Care Med. 1997;25:1721–1726.
- Boehnert MT, Lovejoy FH. Jr. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med. 1985;313:474–479.
- Brandl KM, Langley KA, Riker RR, et al. Confirming the reliability of the sedation-agitation scale administered by ICU nurses without experience in its use. Pharmacotherapy. 2001;21:431–436.
- Shulman MS, Sandler A, Brebner J. The reversal of epidural morphine induced somnolence with physostigmine. Can Anaesth Soc J. 1984;31:678–680.
- Rupreht J. Physostigmine reversal of diazepam. Anesthesiology. 1980;53:180–181.
- Ongini E, Parravicini L, Bamonte F. Effects of physostigmine on benzodiazepine toxicity. Arch Int Pharmacodyn Ther. 1981;253:164–176.
- Eisendrath SJ, Goldman B, Douglas J, et al. Meperidine-induced delirium. Am J Psychiatry. 1987;144:1062–1065.
- Tune LE. Serum anticholinergic activity levels and delirium in the elderly. Semin Clin Neuropsychiatry. 2000;5:149–153.
- Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry. 2001;62 Suppl 21:11–14.
- Furey ML, Khanna A, Hoffman EM, et al. Scopolamine produces larger antidepressant and antianxiety effects in women than in men. Neuropsychopharmacol.. 2010;35:2479–2488.
- Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112–1120.
- Burkhart KK, Magalski AE, Donovan JW. A retrospective review of the use of activated charcoal and physostigmine in the treatment of jimson weed poisoning. J Toxicol Clin Toxicol. 1999;37:389.
- Granja C, Gomes E, Amaro A, JMIP Study Group, et al. Understanding posttraumatic stress disorder-related symptoms after critical care: the early illness amnesia hypothesis. Crit Care Med. 2008;36:2801–2809.
- Davydow DS. Symptoms of depression and anxiety after delirium. Psychosomatics. 2009;50:309–316.
- Myhren H, Ekeberg O, Tøien K, et al. Posttraumatic stress, anxiety and depression symptoms in patients during the first year post intensive care unit discharge. Crit Care. 2010;14:R14.
- Davydow DS, Gifford JM, Desai SV, et al. Posttraumatic stress disorder in general intensive care unit survivors: a systematic review. Gen Hosp Psychiatry. 2008;30:421–434.